NGNE
Price
$18.80
Change
+$1.85 (+10.91%)
Updated
Jan 14 closing price
Capitalization
291.21M
Intraday BUY SELL Signals
TSHA
Price
$5.04
Change
+$0.14 (+2.86%)
Updated
Jan 14 closing price
Capitalization
1.38B
48 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NGNE vs TSHA

Header iconNGNE vs TSHA Comparison
Open Charts NGNE vs TSHABanner chart's image
Neurogene
Price$18.80
Change+$1.85 (+10.91%)
Volume$153.7K
Capitalization291.21M
Taysha Gene Therapies
Price$5.04
Change+$0.14 (+2.86%)
Volume$2.32M
Capitalization1.38B
NGNE vs TSHA Comparison Chart in %
NGNE
Daily Signal:
Gain/Loss:
TSHA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NGNE vs. TSHA commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NGNE is a Hold and TSHA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (NGNE: $18.80 vs. TSHA: $5.04)
Brand notoriety: NGNE and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NGNE: 76% vs. TSHA: 69%
Market capitalization -- NGNE: $291.21M vs. TSHA: $1.38B
NGNE [@Biotechnology] is valued at $291.21M. TSHA’s [@Biotechnology] market capitalization is $1.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NGNE’s FA Score shows that 0 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • NGNE’s FA Score: 0 green, 5 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, TSHA is a better buy in the long-term than NGNE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NGNE’s TA Score shows that 2 TA indicator(s) are bullish while TSHA’s TA Score has 5 bullish TA indicator(s).

  • NGNE’s TA Score: 2 bullish, 5 bearish.
  • TSHA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TSHA is a better buy in the short-term than NGNE.

Price Growth

NGNE (@Biotechnology) experienced а -1.67% price change this week, while TSHA (@Biotechnology) price change was -5.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

TSHA is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($1.38B) has a higher market cap than NGNE($291M). TSHA (-8.364) and NGNE (-8.738) have similar YTD gains . NGNE has higher annual earnings (EBITDA): -82.02M vs. TSHA (-98.71M). TSHA has more cash in the bank: 297M vs. NGNE (265M). NGNE has less debt than TSHA: NGNE (11.3M) vs TSHA (69M). TSHA has higher revenues than NGNE: TSHA (6.31M) vs NGNE (0).
NGNETSHANGNE / TSHA
Capitalization291M1.38B21%
EBITDA-82.02M-98.71M83%
Gain YTD-8.738-8.364104%
P/E RatioN/A2.70-
Revenue06.31M-
Total Cash265M297M89%
Total Debt11.3M69M16%
FUNDAMENTALS RATINGS
NGNE: Fundamental Ratings
NGNE
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NGNETSHA
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
83%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 3 days ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
NGNE
Daily Signal:
Gain/Loss:
TSHA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCBSX34.760.19
+0.55%
Franklin Mutual U.S. Mid Cap Value C
IRFZX9.320.02
+0.22%
Cohen & Steers International Realty Z
TSMUX16.530.01
+0.06%
Nuveen Quant Small/Mid Cap Eq W
FTGFX29.22-0.16
-0.54%
Templeton Growth R6
SLCGX30.84-0.48
-1.53%
Saratoga Large Capitalization Growth I

NGNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NGNE has been loosely correlated with BRNS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NGNE jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGNE
1D Price
Change %
NGNE100%
+10.91%
BRNS - NGNE
51%
Loosely correlated
-0.61%
TSHA - NGNE
50%
Loosely correlated
+2.86%
BCYC - NGNE
49%
Loosely correlated
+2.00%
RNAZ - NGNE
48%
Loosely correlated
+5.62%
STOK - NGNE
46%
Loosely correlated
+1.28%
More

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with PCVX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
+2.86%
PCVX - TSHA
51%
Loosely correlated
+5.41%
NGNE - TSHA
50%
Loosely correlated
+10.91%
RGNX - TSHA
47%
Loosely correlated
-0.66%
SLDB - TSHA
44%
Loosely correlated
+12.60%
BCYC - TSHA
43%
Loosely correlated
+2.00%
More